Prior authorization for ENT procedures: what needs it and when.

Five ENT procedure categories drive most prior-auth denials: balloon sinuplasty, cochlear implants, sleep apnea surgery, revision or advanced FESS, and select allergy panels. Each has its own trigger criteria, its own documentation list, and its own timeline — and none of it is optional paperwork, because a missing authorization denies the claim regardless of how medically necessary the service actually was. This guide names the specific criteria by payer and MAC, plus what to do when authorization is denied versus when the claim denies after the fact for missing it.

The five procedure categories that need prior auth before you schedule

None of these should reach the scheduling desk without an authorization check happening first. The trigger and the documentation differ enough by category that a single generic PA checklist doesn't cover all five.

Balloon sinuplasty: criteria differ by payer, not by a national standard

There is no Medicare LCD standardizing balloon sinuplasty medical necessity, which means every commercial payer's own policy is the actual coverage document you need — not a generic "sinusitis criteria" assumption. Two examples make the point concrete. Blue Cross NC covers balloon dilation of the frontal, maxillary, or sphenoid sinus for uncomplicated sinusitis without polyposis when the patient has either four or more documented acute rhinosinusitis episodes in one year, or chronic sinusitis lasting over 12 weeks with failed optimal medical therapy; a 2026 policy revision added coverage for nasal airway obstruction management even outside those recurrent/chronic sinusitis criteria. Cigna's published policy instead requires symptoms of more than three months' duration, supportive CT findings, and documented failure of at least two full courses of antibiotics plus nasal steroid spray and saline irrigation.

These aren't interchangeable. A patient who clears Blue Cross NC's four-episode threshold may not have the CT documentation Cigna's policy specifically requires, and vice versa. Pull the patient's actual payer policy before building the PA request — not a generalized "balloon sinuplasty is usually covered when medical therapy fails" summary, because the specific proof points differ enough to get a request denied on a technicality even when the underlying case is sound.

Cochlear implants: one national bar, verified directly against the current NCD

Cochlear implantation is the one procedure on this list with a single, uniform national coverage document rather than payer-by-payer variation: NCD 50.3, effective for services on or after September 26, 2022. The criteria are specific enough to build a documentation checklist directly from the NCD text itself.

• 1Bilateral moderate-to-profound sensorineural hearing loss that is pre- or post-linguistic, with limited benefit from appropriate hearing or vibrotactile aids.
• 2Limited benefit is defined numerically: ≤60% correct in the best-aided listening condition on recorded tests of open-set sentence recognition.
• 3Cognitive ability to use auditory cues and willingness to complete an extended rehabilitation program — documented, not assumed.
• 4Freedom from middle ear infection, an accessible and structurally suitable cochlear lumen, and freedom from auditory nerve or central nervous system lesions — typically established by imaging and otologic exam.
• 5No surgical contraindications, and device use consistent with FDA-approved labeling.

Every one of these five has to be met — NCD 50.3 states patients must meet all of the coverage criteria, not most of them. A beneficiary who doesn't meet all five is not covered under Section B at all, except in the context of an FDA-approved investigational device exemption clinical trial or as a routine cost in a qualifying clinical trial. Build the PA request around exactly this list: the audiogram and open-set sentence recognition score, the rehabilitation-readiness note, the imaging or exam ruling out the structural and neurologic exclusions, and the surgical clearance.

Sleep apnea surgery: UPPP and hypoglossal nerve stimulation

Hypoglossal nerve stimulation for obstructive sleep apnea has its own MAC-specific LCD in nearly every jurisdiction, which means the specific numeric criteria — apnea-hypopnea index range, BMI ceiling, degree of CPAP intolerance required — are set contractor by contractor rather than nationally. Confirmed active LCDs, by MAC:

Across every MAC's version, the documentation categories are consistent even where the exact thresholds differ: a polysomnogram or home sleep apnea test establishing the apnea-hypopnea index, documentation the patient failed or could not tolerate CPAP, and typically a drug-induced sleep endoscopy confirming the pattern of airway collapse is appropriate for the device (ruling out complete concentric palatal collapse, which most policies exclude). ⚠️ This build confirmed the LCD IDs, MACs, and effective dates above directly against the CMS Coverage Database, but could not open the full LCD body text to re-confirm the specific AHI range and BMI ceiling each MAC requires — pull your own MAC's current LCD by the ID above before finalizing a PA checklist against it, since these numeric thresholds are exactly the kind of value that varies contractor to contractor and changes on revision.

UPPP (uvulopalatopharyngoplasty) doesn't carry the same MAC-specific LCD structure and is instead reviewed against Medicare's general surgical medical-necessity standards and, for commercial patients, the payer's own sleep-surgery policy — documented OSA diagnosis, failed conservative management, and anatomic findings on exam supporting the specific procedure.

Revision and advanced FESS

Revision sinus surgery draws more PA scrutiny than a first-time FESS, precisely because the payer's underlying question is whether the first procedure failed for a reason the second one actually addresses. The documentation that clears this bar consistently includes the operative note from the prior surgery (what was and wasn't addressed), current CT imaging showing persistent or recurrent disease, and a symptom timeline establishing that conservative management was tried again before proceeding to revision. A request that only restates "patient had FESS previously, symptoms recurred" without connecting the imaging findings to what specifically remains untreated is the version that gets kicked back for more records.

Allergy panels

Extended allergy testing and immunotherapy panels cross PA thresholds on volume, not on the underlying diagnosis. Medicare's own claim-level limits are a useful reference point even for commercial PA thresholds that mirror them: the Medically Unlikely Edit for 95165 (antigen preparation) sits at 30 units per date of service, and 95004 (percutaneous skin testing) carries an 80-test-per-day MUE. Several commercial payers require PA once a panel's requested antigen count or test count approaches these same ranges, even though the specific PA threshold is set by the plan, not by the Medicare MUE itself. Confirm the payer's own panel-size threshold rather than assuming the Medicare unit cap doubles as the commercial PA trigger.

CMS's WISeR AI-assisted prior-auth pilot

CMS's Wasteful and Inappropriate Service Reduction (WISeR) model launched January 1, 2026 as an AI-assisted prior-authorization pilot for Original Medicare in six states: Arizona, New Jersey, Ohio, Oklahoma, Texas, and Washington. In its first program year, hypoglossal nerve stimulation for obstructive sleep apnea is explicitly named as an affected ENT procedure. For Medicare patients in those six states, the authorization request routes through an AI-reviewed pathway rather than the traditional MAC review process, with CMS targeting expedited decisions within 72 hours (48 hours for expedited requests) rather than the standard timeline.

If your practice performs hypoglossal nerve stimulation and operates in any of the six pilot states, this changes the submission workflow, not just the timeline — confirm what the AI-reviewed pathway specifically requires before your next case, because it isn't simply the same LCD documentation routed through a faster reviewer. Balloon sinuplasty, cochlear implants, and revision FESS are not named in WISeR's first-year procedure list, so their authorization workflow is unaffected by the pilot regardless of state.

Workflow: what the PA request needs and what to do when it goes wrong

When an authorization request itself is denied, the appeal path runs through the payer's standard medical-necessity appeal process: resubmit with the specific documentation the denial letter says was missing, and cite the exact policy criteria the record actually meets. When instead a claim denies after the fact because no authorization was on file at all, that's a different and much harder conversation — most payers grant retroactive authorization only in narrow circumstances like emergent care, not for a routine scheduling gap, so the practical fix is almost always prevention rather than appeal. For the broader denial-and-appeal reference across ENT's other high-volume denial categories, see our denials management service overview.

Frequently asked questions

Related resources

• ENT billing and coding guide
• ICD-10 coding for ENT: getting laterality and site right
• Tympanostomy tube placement billing: 69433 vs 69436
• Prior authorization services
• All 25 specialties